(PCVX) - Analyst Ratings

(PCVX) – Analyst Ratings

Dec 6, 2023 04:24 PM Mizuho Securities Starts Vaxcyte (PCVX) at Buy; 'Potential Disruption of a 20-Plus-Year Near Vaccine Monopoly'
Apr 18, 2023 05:31 AM TD Cowen Starts Vaxcyte (PCVX) at Outperform
Dec 15, 2022 06:14 AM
Nov 17, 2022 06:05 AM
Nov 8, 2022 08:15 AM
Jul 13, 2022 06:12 AM
Jun 1, 2022 07:09 AM
Apr 4, 2022 03:53 PM
Feb 24, 2022 06:20 AM
Dec 29, 2021 03:48 AM
Jun 24, 2021 08:05 AM
May 10, 2021 11:51 AM
Jul 7, 2020 10:14 AM
Jul 7, 2020 09:21 AM
Jul 7, 2020 08:47 AM
Jul 7, 2020 05:09 AM